Deutsche Bank’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$51.5M Sell
409,978
-16,956
-4% -$2.13M 0.02% 600
2025
Q1
$47.2M Sell
426,934
-34,848
-8% -$3.85M 0.02% 630
2024
Q4
$63M Buy
461,782
+23,951
+5% +$3.27M 0.02% 581
2024
Q3
$50.4M Buy
437,831
+4,724
+1% +$544K 0.02% 597
2024
Q2
$59.6M Buy
433,107
+73,251
+20% +$10.1M 0.03% 512
2024
Q1
$49.6M Buy
359,856
+22,780
+7% +$3.14M 0.02% 554
2023
Q4
$44.4M Buy
337,076
+59,776
+22% +$7.88M 0.02% 564
2023
Q3
$31.2M Sell
277,300
-80,189
-22% -$9.02M 0.02% 585
2023
Q2
$33.7M Buy
357,489
+17,284
+5% +$1.63M 0.02% 618
2023
Q1
$34.4M Sell
340,205
-345,315
-50% -$35M 0.02% 616
2022
Q4
$81.9M Buy
685,520
+269,065
+65% +$32.1M 0.05% 372
2022
Q3
$44.2M Sell
416,455
-30,979
-7% -$3.29M 0.03% 519
2022
Q2
$43.6M Buy
447,434
+33,960
+8% +$3.31M 0.02% 550
2022
Q1
$38.8M Buy
413,474
+471
+0.1% +$44.2K 0.02% 665
2021
Q4
$35.2M Sell
413,003
-16,655
-4% -$1.42M 0.02% 690
2021
Q3
$41.2M Buy
429,658
+2,455
+0.6% +$235K 0.02% 674
2021
Q2
$41.6M Sell
427,203
-61,403
-13% -$5.98M 0.02% 660
2021
Q1
$47.5M Buy
488,606
+49,521
+11% +$4.82M 0.03% 606
2020
Q4
$42.1M Sell
439,085
-69,910
-14% -$6.7M 0.03% 569
2020
Q3
$48.9M Sell
508,995
-393,169
-44% -$37.8M 0.03% 453
2020
Q2
$110M Buy
902,164
+29,917
+3% +$3.65M 0.08% 229
2020
Q1
$75.5M Sell
872,247
-109,243
-11% -$9.45M 0.07% 277
2019
Q4
$105M Buy
981,490
+86,768
+10% +$9.33M 0.07% 292
2019
Q3
$80.6M Sell
894,722
-9,419
-1% -$849K 0.06% 346
2019
Q2
$76.3M Sell
904,141
-120,494
-12% -$10.2M 0.04% 427
2019
Q1
$90.3M Buy
1,024,635
+189,878
+23% +$16.7M 0.05% 381
2018
Q4
$59.6M Sell
834,757
-92,095
-10% -$6.58M 0.04% 449
2018
Q3
$114M Buy
926,852
+142,723
+18% +$17.5M 0.06% 350
2018
Q2
$77M Sell
784,129
-212,814
-21% -$20.9M 0.04% 488
2018
Q1
$82.7M Buy
996,943
+28,738
+3% +$2.38M 0.04% 459
2017
Q4
$75.1M Sell
968,205
-480,975
-33% -$37.3M 0.05% 404
2017
Q3
$88.8M Buy
1,449,180
+590,160
+69% +$36.2M 0.06% 354
2017
Q2
$39.5M Sell
859,020
-28,714
-3% -$1.32M 0.03% 624
2017
Q1
$38.4M Buy
887,734
+39,549
+5% +$1.71M 0.03% 616
2016
Q4
$32.8M Sell
848,185
-175,010
-17% -$6.77M 0.03% 636
2016
Q3
$51.8M Sell
1,023,195
-239,896
-19% -$12.1M 0.04% 517
2016
Q2
$57.4M Buy
1,263,091
+354,316
+39% +$16.1M 0.04% 467
2016
Q1
$35.9M Sell
908,775
-58,416
-6% -$2.31M 0.03% 633
2015
Q4
$54.7M Sell
967,191
-68,327
-7% -$3.87M 0.04% 496
2015
Q3
$41.2M Buy
1,035,518
+31,591
+3% +$1.26M 0.03% 548
2015
Q2
$47.9M Sell
1,003,927
-49,647
-5% -$2.37M 0.03% 554
2015
Q1
$41.8M Buy
1,053,574
+47,153
+5% +$1.87M 0.03% 593
2014
Q4
$22.5M Buy
1,006,421
+53,051
+6% +$1.19M 0.01% 938
2014
Q3
$14.9M Buy
953,370
+111,004
+13% +$1.74M 0.01% 1093
2014
Q2
$12.5M Buy
842,366
+105,483
+14% +$1.56M 0.01% 1221
2014
Q1
$11.9M Sell
736,883
-319,694
-30% -$5.15M 0.01% 1238
2013
Q4
$9.87M Sell
1,056,577
-332,739
-24% -$3.11M 0.01% 1347
2013
Q3
$15.7M Buy
1,389,316
+211,547
+18% +$2.39M 0.01% 1026
2013
Q2
$15.8M Buy
+1,177,769
New +$15.8M 0.01% 976